journal article·2022-10-14

Star Polymer Nanomedicines─Challenges and Future Perspectives

Helen Forgham, Jiayuan Zhu, Ruirui Qiao, Thomas P. Davis

ACS Applied Polymer Materials· Volume 4· Issue 10
Publisher page

Abstract

Star polymers are structures composed of multiple functional linear arms covalently connected through a central core. The unique conformation of star polymers, with their tunable side arms and architectural plasticity, makes them well equipped to deliver pharmaceutical drugs and biologicals (peptides, nucleic acids), and design imaging agents. A great deal has been reported on the design and synthesis of star polymers, with several studies demonstrating the possibility for future translation. In this work, we have for the first time performed a review on research published over the last 5-years, focused on the translation of star polymer nanoparticles toward therapeutic application. We discuss all the important potential translational breakthroughs in the field as well as offering a perspective on how the addition of cutting-edge in vitro and in vivo models could provide us with the tools for the successful future clinical translation of star polymer nanoparticles.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · MXene and MAX Phase Materials · Dendrimers and Hyperbranched Polymers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Australian Institute of Bioengineering & Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia

Funding

National Health and Medical Research Council · University of Queensland

References (58)

Show source-provided references
1. 10.1021/acs.chemrev.6b0000810.1021/acs.chemrev.6b00008 ↗
2. 10.1071/CH1739110.1071/CH17391 ↗
3. 10.1038/s41580-018-0045-710.1038/s41580-018-0045-7 ↗
4. 10.1038/s41573-019-0017-410.1038/s41573-019-0017-4 ↗
5. 10.1021/acs.biomac.6b0018510.1021/acs.biomac.6b00185 ↗
6. 10.3390/pharmaceutics1209082710.3390/pharmaceutics12090827 ↗
7. 10.1016/j.biomaterials.2022.12153910.1016/j.biomaterials.2022.121539 ↗
8. 10.1021/acsomega.7b0163210.1021/acsomega.7b01632 ↗
9. 10.1038/ncomms1111910.1038/ncomms11119 ↗
10. 10.1021/acs.macromol.8b0232110.1021/acs.macromol.8b02321 ↗
11. 10.1002/adhm.20140016410.1002/adhm.201400164 ↗
12. 10.1021/ml400082b10.1021/ml400082b ↗
13. 10.1002/marc.20120002910.1002/marc.201200029 ↗
14. 10.1002/marc.20170041010.1002/marc.201700410 ↗
15. 10.1021/acs.biomac.1c0029610.1021/acs.biomac.1c00296 ↗
16. 10.1016/j.nano.2015.08.00110.1016/j.nano.2015.08.001 ↗
17. 10.1016/j.xphs.2015.11.03810.1016/j.xphs.2015.11.038 ↗
18. Baas J. · Z. Gastroenterol. · 1994 · 32 · 117
19. 10.2147/IJN.S22032610.2147/IJN.S220326 ↗
20. 10.1038/s41388-018-0666-510.1038/s41388-018-0666-5 ↗
21. 10.1016/j.msec.2021.11252910.1016/j.msec.2021.112529 ↗
22. 10.1155/2016/648025910.1155/2016/6480259 ↗
23. 10.1016/j.biomaterials.2019.11972810.1016/j.biomaterials.2019.119728 ↗
24. 10.1371/journal.pone.023384410.1371/journal.pone.0233844 ↗
25. 10.1016/j.jconrel.2011.06.01510.1016/j.jconrel.2011.06.015 ↗
26. 10.1016/j.jconrel.2020.03.00210.1016/j.jconrel.2020.03.002 ↗
27. 10.1007/s11095-016-1958-510.1007/s11095-016-1958-5 ↗
28. 10.1016/j.nano.2014.04.01210.1016/j.nano.2014.04.012 ↗
29. 10.3390/cancers1310242710.3390/cancers13102427 ↗
30. 10.1039/D2BM00181K10.1039/D2BM00181K ↗
31. 10.1186/s12951-020-00595-510.1186/s12951-020-00595-5 ↗
32. 10.1042/bse038002110.1042/bse0380021 ↗
33. 10.2147/IJN.S19821710.2147/IJN.S198217 ↗
34. 10.1021/mp400049e10.1021/mp400049e ↗
35. 10.1007/978-1-4939-9220-1_2310.1007/978-1-4939-9220-1_23 ↗
36. 10.1158/0008-5472.CAN-20-249610.1158/0008-5472.CAN-20-2496 ↗
37. 10.18632/oncotarget.266410.18632/oncotarget.2664 ↗
38. 10.1038/srep4473510.1038/srep44735 ↗
39. 10.1038/nbt.186610.1038/nbt.1866 ↗
40. 10.3389/fphar.2020.0116510.3389/fphar.2020.01165 ↗
41. 10.1016/j.bioactmat.2021.03.02610.1016/j.bioactmat.2021.03.026 ↗
42. 10.1039/c3py00656e10.1039/c3py00656e ↗
43. 10.1016/j.molcel.2021.11.02610.1016/j.molcel.2021.11.026 ↗
44. 10.7150/thno.3677710.7150/thno.36777 ↗
45. 10.1016/j.nucmedbio.2020.02.01210.1016/j.nucmedbio.2020.02.012 ↗
46. 10.1021/ja410351h10.1021/ja410351h ↗
47. 10.1124/pr.112.00599110.1124/pr.112.005991 ↗
48. 10.1016/j.neuron.2015.11.00110.1016/j.neuron.2015.11.001 ↗
49. 10.1016/j.biomaterials.2022.12153610.1016/j.biomaterials.2022.121536 ↗
50. 10.1038/s41565-019-0568-x10.1038/s41565-019-0568-x ↗
51. 10.1021/acs.accounts.9b0022810.1021/acs.accounts.9b00228 ↗
52. 10.1021/acsnano.5b0132410.1021/acsnano.5b01324 ↗
53. 10.1038/s41563-019-0566-210.1038/s41563-019-0566-2 ↗
54. 10.1016/j.biomaterials.2019.11974210.1016/j.biomaterials.2019.119742 ↗
55. 10.1038/s41580-020-0259-310.1038/s41580-020-0259-3 ↗
56. 10.1088/1758-5090/ac2ef910.1088/1758-5090/ac2ef9 ↗
57. 10.1002/smll.20200286110.1002/smll.202002861 ↗
58. 10.1002/aisy.20190012610.1002/aisy.201900126 ↗